{
    "title": "103_hr4809",
    "content": "The Act titled \"Prostate Cancer Diagnosis and Treatment Act of 1994\" allows for Medicare coverage of prostate cancer screening and certain drug treatments. The \"Prostate Cancer Diagnosis and Treatment Act of 1994\" expands Medicare coverage to include prostate cancer screening services. The \"Prostate Cancer Diagnosis and Treatment Act of 1994\" expands Medicare coverage to include prostate cancer screening services. The Reconciliation Act of 1990 amends subsection (kk) and adds a new subsection. The \"Prostate Cancer Screening Services\" are now covered by Medicare under the Prostate Cancer Diagnosis and Treatment Act of 1994. The term 'prostate cancer screening services' includes digital rectal examination, prostate-specific antigen blood test, transrectal ultrasonography, and other designated procedures for early detection. Payment amounts and frequency limits for these services are specified in the Medicare Act. Payment for cancer screening services is limited to the frequency allowed and covers 80% of the actual charge. The payment amount is based on the fee schedule for the specific screening service. The payment for cancer screening services is limited to the frequency allowed and covers 80% of the actual charge based on the fee schedule. Prostate cancer screening services are not covered if the individual is under 50 years of age or if the service is provided within 11 months after a previous screening. The payment for prostate cancer screening services is limited to a certain frequency, but exceptions can be made for high-risk individuals. The Secretary periodically reviews the appropriate screening frequency based on age and other factors. The Secretary establishes fee schedules for payment of prostate cancer screening services, excluding PSA tests, based on geographic considerations. The frequency of payment may be revised periodically, but changes do not apply retroactively before January 1, 1998. The Secretary establishes fee schedules for payment of prostate cancer screening services, excluding PSA tests, based on geographic considerations and other relevant factors to ensure equitable payment amounts. Nonparticipating physicians are limited in their charges for providing these services. The Secretary sets fee schedules for prostate cancer screening services, with limits on charges by nonparticipating physicians. Sanctions may be imposed for willful violations. Conforming amendments are made to related sections of the Act. Section 1833(a) of the Act is amended to include provisions for prostate cancer screening services, specifically regarding payment amounts. Amendments also address limits on charges by nonparticipating physicians and potential sanctions for violations. Amendments are made to various sections of the Act, including provisions for prostate cancer screening services payment amounts. Changes involve adding a new paragraph for these services and adjusting sections related to the Secretary's authority and coding for specific services. Amendments to Section 1862(a) of the Act include adding a new subparagraph (G) for prostate cancer screening services performed more frequently than covered under section 1834(d)(2). Amendments to Section 1861(s)(2) of the Social Security Act include coverage for an oral drug prescribed for prostate cancer treatment, effective from January 1, 1995. The Social Security Act was amended to include coverage for an oral drug prescribed for prostate cancer treatment, effective from January 1, 1995. Section 1834(d)(3) was added to the Act to carry out these amendments by a specified date. SEC. 3. COVERAGE OF PROSTATE CANCER SCREENING AND TREATMENT SERVICES FOR VETERANS. The amendment includes prostate cancer screening and diagnostic tests as preventive health services for veterans. It also mandates coverage for prostate cancer screening, counseling, treatment, and information under Chapter 17 of title 38, United States Code. The Secretary shall develop and implement an appropriate prostate cancer screening schedule for veterans confined to hospitals or institutions, including digital rectal examinations, PSA blood tests, and ultrasonography. Prostate cancer treatment includes FDA-approved drugs. Research and training in prostate cancer diagnosis and treatment may be conducted based on services provided under this section. The Secretary may develop guidelines for effective prostate cancer treatment regimens under this section. A clerical amendment is made to insert a new item in the table of sections. Research and education on prostate cancer, including screening and treatment programs, are addressed in this section. The Secretary may establish guidelines for effective treatment regimens. The Public Health Service Act is amended to allocate specific funding for fiscal years 1994-1998. The Administrator is tasked with conducting research on prostate cancer outcomes and updating clinical guidelines. The Administrator is responsible for developing, reviewing, and updating clinically relevant guidelines and standards."
}